The Pseudomonas aeruginosa product pyochelin interferes with Trypanosoma cruzi infection and multiplication in vitro
Open Access
- 1 July 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 114 (7) , 492-498
Abstract
Bacteria are sources of numerous molecules used in treatment of infectious diseases. We investigated effects of molecules produced by 26 Pseudomonas aeruginosa strains against infection of mammalian cell cultures with Trypanosoma cruzi, the aetiological agent of Chagas disease. Vero cells were infected with T. cruzi in the presence of wild-type P. aeruginosa supernatants or supernatants of mutants with defects in the production of various virulence, quorum sensing and iron acquisition factors. Quantification of T. cruzi infection (percentage of infected cells) and multiplication (number of amastigotes per infected cell) was performed and cell viability was determined. Wild-type P. aeruginosa products negatively affected T. cruzi infection and multiplication in a dose-dependent manner, without evident toxicity for mammalian cells. PvdD/pchE mutation (loss of the P. aeruginosa siderophores pyoverdine and pyochelin) had the greatest impact on anti–T. cruzi activity. Negative effects on T. cruzi infection by pure pyochelin, but not pyoverdine, or other P. aeruginosa exoproducts studied, were quantitatively similar to the effects of benznidazole, the current standard therapy against T. cruzi. The P. aeruginosa product pyochelin showed promising activity against T. cruzi and might become a new lead molecule for therapy development.Keywords
Funding Information
- Foundation for Research in Infectious Diseases (CIMR3424)
- National Institutes of Health (5SC3GM118199)
- National Science Foundation (DUE 1258366)
This publication has 34 references indexed in Scilit:
- Chagas disease: a new worldwide challengeNature, 2010
- The Pseudomonas aeruginosa Pyochelin-Iron Uptake Pathway and Its Metal SpecificityJournal of Bacteriology, 2009
- The natural history of antibioticsCurrent Biology, 2009
- Pseudomonas aeruginosa lipopolysaccharide: A major virulence factor, initiator of inflammation and target for effective immunityInternational Journal of Medical Microbiology, 2007
- Innovative lead discovery strategies for tropical diseasesNature Reviews Drug Discovery, 2006
- The contribution of MvfR to Pseudomonas aeruginosa pathogenesis and quorum sensing circuitry regulation: multiple quorum sensing‐regulated genes are modulated without affecting lasRI, rhlRI or the production of N‐acyl‐ l‐homoserine lactonesMolecular Microbiology, 2005
- Trypanosoma cruzi response to the oxidative stress generated by hydrogen peroxideMolecular and Biochemical Parasitology, 2004
- Interaction of the Pseudomonas aeruginosa secretory products pyocyanin and pyochelin generates hydroxyl radical and causes synergistic damage to endothelial cells. Implications for Pseudomonas-associated tissue injury.Journal of Clinical Investigation, 1992
- Enhanced Multiplication of Intracellular (Amastigote) Stages ofTrypanosoma cruziIn Vitro1The Journal of Protozoology, 1984
- Role of iron in Trypanosoma cruzi infection of mice.Journal of Clinical Investigation, 1984